Isa Marte Hussaini, a professor of Pharmacology and Fellow of the Nigeria Academy of Pharmacy (NAPharm), has been appointed as a commissioner by the Borno State government.
Hussaini, who made the disclosure of his appointment to Pharmanewsonline.com, said he was among the Twenty-two nominees for the position who were cleared by the Borno State House of Assembly recently.
Addressing the youths of Borno State in an amateur video on Facebook, the newly appointed commissioner, who was speaking on behalf of the Governor of the state, Babagana Umara Zulum assured them of turning everything around for the better in the next four years.
As an erudite scholar and researcher, Prof. Hussaini has been at the forefront in the search and investigation of useful local medical plants for cancer treatment. In 2015, he presented one of his latest research findings to the Nigerian Academy of Science at the induction ceremony of Fellows in Abuja where he stated that some Nigerian herbal plants are more efficacious than the current drugs used in cancer treatments. Similarly, on 12 February 2016, he presented a lecture, titled “Exploitation of medicinal plant compounds in the search for novel cancer therapeutic agents” in an event hosted by Professor Louise Serpell through the Sussex Nigerian Society, University of Sussex Genome Damage and Stability Centre, UK.
For his outstanding contributions to cancer research in Nigeria, Prof. Hussaini was made a Fellow of Nigeria Academy of Science in 2013 and in November 2015, he was made a Fellow of Nigeria Academy of Pharmacy. He became a Fellow of the Pharmaceutical Society of Nigeria in 2016. He is also a founding member of the International Society of Neuro-Oncology (SNO).
The renowned scholar has, to his credit, 105 peer-reviewed journal publications and five book chapters which have been cited over 3,200 times by other researchers worldwide. Prof. Hussaini has spoken at over 20 international conferences and symposia and he has been invited as a guest lecturer in many universities throughout the world.
The management and staff of Pharmanews join his family, friends and associates to wish him a successful tenure ahead.